Filtrona well positioned for further growth
Speciality plastic, fibre and foam products supplier Filtrona said it is well positioned to deliver growth for the full year as it reported a 24 per cent increase in half year revenue.
Speciality plastic, fibre and foam products supplier Filtrona said it is well positioned to deliver growth for the full year as it reported a 24 per cent increase in half year revenue.
Revenue at constant FX grew to £324.8m for the half year ended 30 June 2012 from £268.6m the same time a year earlier. Like for like revenue increased 9% after progress at all its major divisions.
Pre-tax profit rose to £40.8m from £37.8m in the same period last year. Adjusted operating profit rose 26% while adjusted operating margin grew 30bps to 16.7%.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
"Given this performance, Filtrona remains well-positioned to deliver further balanced growth in 2012," said chief executive Colin Day.
Net debt rose to £183m from £145m previously, after the £36m acquisition spend on Lymtech Scientific, Jae Yong and Securit.
Filtrona raised its first-half dividend by 18% to 3.9p per share.
As at June 30, the group's gross pension liability was £27.1m, up from £12.7m a year earlier.
CJ
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Invest like a tortoise, not a hare to avoid market volatility
Opinion Hassan Raza, Portfolio Manager at CG Asset Management, highlights three favourite investment companies
-
Should I get a financial adviser?
Getting a financial adviser could be the best investment you make, but who really needs one and do they add any value?